These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 7518295)

  • 1. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
    Kahl U; Langel U; Bartfai T; Grundemar L
    Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand binding and functional effects of systematic double D-amino acid residue substituted neuropeptide Y analogs on Y1 and Y2 receptor types.
    Grundemar L; Kahl U; Callréus T; Langel U; Bienert M; Beyermann M
    Regul Pept; 1996 Apr; 62(2-3):131-6. PubMed ID: 8795076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of chimeric NPY/galanin peptides M32 and M242 to cloned neuropeptide Y receptor subtypes Y1, Y2, Y4, and Y5.
    Berglund MM; Saar K; Lundell I; Langel U; Larhammar D
    Neuropeptides; 2001; 35(3-4):148-53. PubMed ID: 11884204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of neuropeptide Y1 and neuropeptide Y2 receptors by substituted and truncated neuropeptide Y analogs: identification of signal epitopes.
    Grundemar L; Krstenansky JL; Håkanson R
    Eur J Pharmacol; 1993 Mar; 232(2-3):271-8. PubMed ID: 8467862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Solution structure by 2D 1H-NMR of a chimeric peptide recognized by galanin and neuropeptide Y receptors.
    Arvidsson K; Land T; Langel U; Bartfai T; Ehrenberg A
    Biochemistry; 1993 Aug; 32(30):7787-98. PubMed ID: 7688568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-function studies on neuropeptide Y and pancreatic polypeptide--evidence for two PP-fold receptors in vas deferens.
    Jørgensen JC; Fuhlendorff J; Schwartz TW
    Eur J Pharmacol; 1990 Sep; 186(1):105-14. PubMed ID: 2178092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
    Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
    Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Y3 receptor-mediated synaptic inhibition by chimeric neuropeptide Y-peptide YY peptides in the rat brainstem.
    Glaum SR; Miller RJ; Rhim H; Maclean D; Georgic LM; MacKenzie RG; Grundemar L
    Br J Pharmacol; 1997 Feb; 120(3):481-7. PubMed ID: 9031753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
    Grundemar L
    Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of various neuropeptide Y/peptide YY fragments on electrically-evoked contractions of the rat vas deferens.
    Grundemar L; Håkanson R
    Br J Pharmacol; 1990 May; 100(1):190-2. PubMed ID: 2372659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional distribution of putative NPY Y1 receptors and neurons expressing Y1 mRNA in forebrain areas of the rat central nervous system.
    Larsen PJ; Sheikh SP; Jakobsen CR; Schwartz TW; Mikkelsen JD
    Eur J Neurosci; 1993 Dec; 5(12):1622-37. PubMed ID: 8124516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of truncated neuropeptide Y analogues with modifications of the tyrosine residue in position 1 on Y1, Y2 and Y3 receptor sub-types.
    Dumont Y; Satoh H; Cadieux A; Taoudi-Benchekroun M; Pheng LH; St-Pierre S; Fournier A; Quirion R
    Eur J Pharmacol; 1993 Jul; 238(1):37-45. PubMed ID: 8405081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of vascular neuropeptide Y receptors.
    Grundemar L; Jonas SE; Mörner N; Högestätt ED; Wahlestedt C; Håkanson R
    Br J Pharmacol; 1992 Jan; 105(1):45-50. PubMed ID: 1317737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the solution structures of the chimeric peptides galanin(1-12)-Ala-neuropeptide Y(25-36)amide and galanin(1-12)-Pro-neuropeptide Y(25-36)amide.
    Arvidsson K; Langel U; Ehrenberg A
    Eur J Biochem; 1994 Jun; 222(2):573-81. PubMed ID: 8020494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and characterization of a selective peptide antagonist of neuropeptide Y vascular postsynaptic receptors.
    Lew MJ; Murphy R; Angus JA
    Br J Pharmacol; 1996 Apr; 117(8):1768-72. PubMed ID: 8732289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y Y1 receptor mechanisms in sympathetic vascular control.
    Malmström RE
    Acta Physiol Scand Suppl; 1997; 636():1-55. PubMed ID: 9179320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y-Y1 receptor antagonist.
    Hegde SS; Bonhaus DW; Stanley W; Eglen RM; Moy TM; Loeb M; Shetty SG; DeSouza A; Krstenansky J
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1261-6. PubMed ID: 8531090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational and biological studies of neuropeptide Y analogs containing structural alterations.
    Fournier A; Gagnon D; Quirion R; Cadieux A; Dumont Y; Pheng LH; St-Pierre S
    Mol Pharmacol; 1994 Jan; 45(1):93-101. PubMed ID: 8302286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide YY derivatives as selective neuropeptide Y/peptide YY Y1 and Y2 agonists devoided of activity for the Y3 receptor sub-type.
    Dumont Y; Cadieux A; Pheng LH; Fournier A; St-Pierre S; Quirion R
    Brain Res Mol Brain Res; 1994 Oct; 26(1-2):320-4. PubMed ID: 7854062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discrimination by benextramine between the NPY-Y1 receptor subtypes present in rabbit isolated vas deferens and saphenous vein.
    Palea S; Corsi M; Rimland JM; Trist DG
    Br J Pharmacol; 1995 May; 115(1):3-10. PubMed ID: 7647980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.